LJPC Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 aug 2022 @ 22:00):

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases...

Stats
Dagens volum	960 928
Gjennomsnittsvolum	0
Markedsverdi	0.00
EPS	$0.0766 ( Q2 \| 2022-08-15 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	47.62 (Sector) 42.63 (Industry) 24.32
ATR14	$0.137 (2.20%)

AADI -8.24%

ABCL 0.73%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 3.97%

ABSI 3.73%

ABUS -0.82%

ABVX -3.00%

ACAD -0.45%

ACER -17.95%

ACET -9.33%

ACGN 1.29%

ACHL -2.48%

ACHV 3.66%

ACIU -1.50%

ACLX -0.30%

ACRV -5.28%

ACST -1.68%

ACXP 3.92%

ADAG 6.07%

ADAP -3.42%

ADGI 0.87%

ADIL -1.75%

ADMA -1.95%

ADPT 1.03%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -2.62%

AGEN -3.56%

AGIO -2.08%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.48%

AKRO -2.64%

AKTX 0.35%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.00%

ALGS 1.32%

ALKS 1.65%

ALLK -11.02%

ALLO -4.17%

ALLR -2.07%

ALNA 3.16%

ALNY 2.21%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -14.14%

ALVR -0.66%

ALXN 0.00%

ALXO -14.16%

ALZN 4.02%

AMRN -1.26%

AMTI -3.13%

ANAB 1.00%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.97%

ANPC -3.15%

APGE 0.52%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.61%

APLT -0.90%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.49%

ARDS -12.13%

ARDX 0.42%

ARGX -0.59%

ARNA 0.00%

ARPO -0.90%

ARQT -3.07%

ARTL -2.50%

ARTLW 0.00%

ARVN 8.14%

ARWR -1.97%

ASLN -3.44%

ASMB -4.22%

ASND -2.14%

ATAI -4.81%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.60%

ATXI -2.77%

ATXS -0.78%

AUPH -1.17%

AURA 4.26%

AUTL -3.74%

AVBP -6.52%

AVEO 0.00%

AVIR -2.19%

AVRO -1.41%

AVTE -1.03%

AVTX -3.74%

AVXL -5.19%

AXLA 0.00%

AXSM -1.47%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.63%

BCAB -5.26%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.48%

BCRX 1.81%

BCTX 10.31%

BCTXW 13.02%

BCYC 1.00%

BDRX -4.06%

BDTX -0.64%

BEAM 2.25%

BFRA -2.91%

BGNE -2.25%

BIOR -4.69%

BIVI 2.79%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.46%

BLTE -1.13%

BLU 0.03%

BLUE -2.28%

BMEA -14.20%

BMRN 0.51%

BNOX 6.15%

BNTC -3.06%

BNTX -1.72%

BOLD -8.97%

BOLT -0.05%

BPMC -1.55%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -5.19%

BTAI 12.29%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 1.52%

CADL 0.71%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.86%

CARA -3.23%

CARM 7.39%

CASI 4.08%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.87%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 8.62%

CELC -3.46%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.45%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.09%

CGEN -3.31%

CGON -1.45%

CGTX -4.35%

CHMA -6.00%

CHRS 4.43%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -1.19%

CLGN 0.00%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.01%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.61%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.25%

CNST 0.00%

CNTA 0.45%

CNTB -0.75%

CNTX -5.95%

COCP -2.00%

COEPW 32.45%

COGT -2.29%

CORT 2.47%

COYA -0.49%

CPRX -1.91%

CRBP -0.74%

CRBU -7.10%

CRDF 0.67%

CRGX -0.74%

CRIS -1.59%

CRNX -6.31%

CRSP -0.16%

CRTX 2.63%

CRVO -3.95%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR -1.15%

CUE -3.11%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.88%

CYTO 0.00%

DARE 2.92%

DAWN -0.97%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 25.94%

DNLI -2.10%

DNTH -6.27%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL 0.63%

DYAI 9.68%

EARS -1.77%

EDIT -2.84%

EDSA 4.09%

EFTR 2.51%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.40%

ELEV -2.07%

ELOX 10.77%

ELTX -5.15%

ELVN -1.17%

ELYM 5.09%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.73%

ENTO -4.97%

ENTX -1.33%

ENVB 4.72%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.20%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.45%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.00%

EVLO 0.00%

EWTX -1.21%

EXAI -0.76%

EXEL 0.47%

EYEG -0.69%

EYEN 0.00%

EYPT 0.97%

FATE -11.95%

FBIO 0.59%

FBIOP 0.87%

FBLG -4.80%

FBRX -0.02%

FDMT -5.55%

FENC -2.52%

FGEN -10.26%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.57%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.31%

FULC 1.17%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -2.88%

GHRS -3.72%

GLMD -4.09%

GLPG -1.71%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -12.46%

GMAB -0.39%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.35%

GNLX -4.65%

GNPX -3.43%

GNTA 3.94%

GOSS -9.55%

GOVX -1.36%

GOVXW 10.89%

GPCR -6.91%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.32%

GRTX -1.66%

GTHX 1.59%

GUTS 0.34%

GXGXW 41.67%

GYRE -4.97%

HALO -1.66%

HARP 0.09%

HCWB -6.13%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.97%

HOTH -1.64%

HOWL 0.63%

HRMY 3.87%

HRTX 8.36%

HSTO 0.00%

HUMA 1.12%

HUMAW -6.26%

IBRX -6.31%

ICCC -3.10%

ICPT 0.21%

ICU 16.82%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.21%

IFRX -2.78%

IGMS -1.46%

IKNA -1.18%

IKT -9.93%

IMAB 0.00%

IMCR -3.34%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 3.60%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.37%

IMTXW 6.00%

IMUX 2.30%

IMV 0.00%

IMVT -3.52%

INAB -0.72%

INBX -2.72%

INCY -2.27%

INDP 7.34%

INFI -52.38%

INKT 1.68%

INM 0.04%

INMB 3.91%

INO 2.67%

INSM -1.06%

INTS -1.96%

INVA 0.28%

INZY 2.06%

IOBT -9.45%

IONS 1.21%

IOVA -2.78%

IPA 3.00%

IPHA 5.18%

IPSC -2.73%

IRON -2.67%

ISEE 0.38%

ITOS 1.50%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.54%

JANX -4.56%

JAZZ -1.01%

JNCE 0.00%

JSPR -2.25%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.15%

KDNY 0.22%

KMPH -0.34%

KNSA -2.03%

KNTE -0.38%

KOD -7.71%

KPRX -4.08%

KPTI -8.74%

KRBP -10.00%

KRON 1.58%

KROS -0.53%

KRRO -1.49%

KRTX 0.03%

KRYS 0.11%

KTRA 13.87%

KTTA -0.65%

KTTAW 0.92%

KURA 0.68%

KYMR -3.37%

KYTX -4.13%

KZIA 0.35%

KZR -0.21%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.78%

LENZ -2.78%

LEXX -1.54%

LEXXW -14.63%

LGND -1.18%

LGNDV 0.00%

LGVN -10.61%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA 0.00%

LRMR -0.06%

LSTA -1.68%

LTRN 5.74%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -2.05%

LYEL -35.05%

LYRA 3.99%

MACK 0.10%

MBIO -11.34%

MBRX -1.43%

MCRB 2.94%

MDGL -2.24%

MDNA -13.16%

MDWD 3.56%

MDXG -2.28%

MEIP 0.00%

MESO -1.70%

MGNX -5.13%

MGTA -7.74%

MGTX -0.71%

MGX 2.14%

MIRM 0.45%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -5.95%

MLECW 2.31%

MLND -5.36%

MLTX -0.03%

MLYS -6.08%

MNKD -0.76%

MNMD 2.97%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.13%

MREO -1.00%

MRKR -0.43%

MRNA -9.19%

MRNS -5.88%

MRSN -2.62%

MRTX -0.17%

MRUS -0.43%

MRVI 0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.00%

NAMSW -0.21%

NAUT 0.89%

NBRV 0.71%

NBSE -1.56%

NBTX 8.40%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.18%

NKGN 9.85%

NKGNW -18.03%

NKTR 3.74%

NKTX -3.59%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.94%

NMTR -42.97%

NOVN -24.84%

NRBO 14.93%

NRIX -0.72%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.46%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.62%

NTEC -12.45%

NTHI 0.00%

NTLA -5.42%

NTRBW -31.07%

NUVL -1.27%

NVAX -7.79%

NVCT -7.46%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 3.04%

OABIW -10.06%

OBIO 1.90%

OBSV 0.00%

OCEA -2.82%

OCGN 8.47%

OCS -1.00%

OCUL 0.84%

OCUP 1.31%

ODT -4.27%

OKYO 1.72%

OLMA -5.12%

OMER -2.57%

OMGA 0.00%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -4.00%

ORGS -0.69%

ORIC -3.41%

ORMP 18.04%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.25%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.69%

PBYI 2.87%

PCSA -1.93%

PCVX -0.19%

PDSB -7.12%

PEPG 1.19%

PGEN -6.59%

PHAR 2.19%

PHAS 0.00%

PHAT -0.53%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.47%

PLUR 7.39%

PMN -5.55%

PMVP -2.98%

PNT 0.16%

PPBT -6.87%

PRAX 7.28%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.45%

PRQR 1.17%

PRTA -2.89%

PRTC 0.62%

PRTG 0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.97%

PSTX -2.91%

PTCT -0.80%

PTE -0.82%

PTGX -1.32%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 3.75%

QLGN -2.78%

QNCX 5.70%

QNRX -0.08%

QSI -31.62%

QSIAW -3.13%

QTTB 1.83%

QURE -0.90%

RAIN -1.63%

RANI 4.81%

RAPT -1.95%

RARE 1.91%

RCKT -9.87%

REGN -0.36%

RENB -4.04%

REPL -2.27%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.66%

RIGL -6.24%

RLAY -4.90%

RLMD 0.00%

RLYB -4.36%

RNA 1.72%

RNAC -4.53%

RNAZ -0.96%

RNXT 1.79%

ROIV -1.94%

ROIVW 4.56%

RPHM -1.55%

RPRX -0.61%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.93%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.50%

RYTM -6.39%

RYZB 0.02%

RZLT 1.94%

SABS -1.37%

SABSW -11.81%

SAGE -0.18%

SANA -2.95%

SAVA -2.10%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 9.85%

SCPS 0.00%

SEEL -6.79%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.56%

SGTX -2.56%

SIOX 22.63%

SLDB -2.41%

SLGL 5.23%

SLN -7.25%

SLNO 0.74%

SLRX -0.81%

SLS -2.57%

SMMT -3.62%

SNDX 2.81%

SNGX 2.08%

SNPX 0.23%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.29%

SRRA 0.00%

SRRK -1.73%

SRZN -2.45%

STAB 0.00%

STOK -7.21%

STRO -2.51%

STSA 0.00%

STTK 6.62%

SURF -0.93%

SVRA -1.84%

SWTX -0.48%

SYBX 1.29%

SYRS -2.24%

TALS -0.73%

TARA -7.38%

TARS -2.17%

TBPH 0.71%

TCBP 9.58%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 4.77%

TECH -0.86%

TENX -0.32%

TERN -8.28%

TFFP -7.61%

TGTX -7.40%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.26%

TNGX -3.24%

TNXP -6.43%

TNYA -4.03%

TPST 5.34%

TRDA -4.81%

TRVI 2.68%

TRVN 0.67%

TSHA -18.86%

TSVT -4.26%

TTNP -6.05%

TVTX 3.02%

TYRA -6.95%

UBX -2.13%

UNCY -4.00%

URGN 2.49%

UTHR -0.18%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.91%

VBLT -8.77%

VCEL 0.98%

VCNX 8.60%

VCYT -0.92%

VERA -5.42%

VERU 3.02%

VERV -2.68%

VIGL -1.08%

VINC 2.93%

VIR -1.08%

VIRI -5.72%

VIRX 3.98%

VKTX -1.72%

VLON -13.04%

VNDA -4.07%

VOR -6.05%

VRCA 0.28%

VRDN -4.15%

VRNA -1.99%

VRPX 1.02%

VRTX 0.09%

VSTM 3.91%

VTGN -1.20%

VTVT 0.39%

VTYX -2.93%

VXRT -1.86%

VYGR -0.83%

VYNE -6.29%

VYNT 7.78%

WINT -2.72%

WVE -9.33%

XBIO 1.03%

XBIT 6.72%

XCUR 3.13%

XENE -1.76%

XERS 4.77%

XFOR 4.71%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -9.99%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.72%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-08-22	Rosen Robert	Sell	30 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	18 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)
2022-08-22	Rosen Robert	Sell	10 000	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 100 transactions
Buy: 0 \| Sell: 11 680 911

Volum Korrelasjon

Lang: 0.33 (neutral)

Kort: -0.74 (moderate negative)

Signal:(78.937) Neutral

La Jolla Pharmaceutical Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

La Jolla Pharmaceutical Korrelasjon - Valuta/Råvare

0.29
( neutral )

-0.63
( weak negative )

0.77
( moderate )

0.37
( neutral )

-0.47
( neutral )

-0.54
( weak negative )

La Jolla Pharmaceutical Økonomi

Annual	2021
Omsetning:	$75.72M
Bruttogevinst:	$62.23M (82.19 %)
EPS:	$0.720

FY	2021
Omsetning:	$75.72M
Bruttogevinst:	$62.23M (82.19 %)
EPS:	$0.720

FY	2020
Omsetning:	$33.42M
Bruttogevinst:	$25.60M (76.60 %)
EPS:	$-1.440

FY	2019
Omsetning:	$23.05M
Bruttogevinst:	$20.66M (89.62 %)
EPS:	$-4.30

Financial Reports:

No articles found.

La Jolla Pharmaceutical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

La Jolla Pharmaceutical

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.